NCT05762367

Brief Summary

In the brain and its borders, blood vessels coexist with lymphatic vessels exclusively in the dura mater, the outermost layer of meninges. Dural lymphatics are present in various vertebrate species, including humans, and a cluster of experimental studies in the mouse strongly suggest their relevance in the pathophysiology of chronic and acute neurological disorders in humans. Demonstrating this assumption is however still at stake and the lymphatic regulatory mechanisms involved remain poorly characterized. Our main objective is to assess dural lymphatics contribution to the pathophysiology of a rare neurological disorder: idiopathic intracranial hypertension (IIH). In IIH patients, intracranial hypertension causes severe headache and visual loss and is associated with a stenosis of dural sinuses and abnormal retention of fluids in the central nervous system. Angioplasty treatment by stent placement into venous sinuses is frequently followed by recurrent stenosis suggesting that, in addition to the blood vessels, the duro-lymphatic environment contributes to disease progression. Several studies have found hot spots of lymphatic uptake at confluence points between cerebral veins and dural sinuses. Based on this premise, the investigators predict a causal link between lymphatic and venous behavior around dural sinuses and the remodeling of dural lymphatics in neurovascular conditions such as IIH. Our approach will combine radiological observations from human patients with experimental analyses in mouse models. The investigators have recently developed a technique of high resolution vessel wall imaging to explore and compare the lymphatic networks between individuals. This advanced MR-imaging technique has been validated through a translational study comparing the lymphatic networks in mice and humans (Jacob et al. 2022, JExpMed). Using this tool, the investigators aim to monitor dural lymphatic and sinus wall abnormalities in patients with IIH. In this view, cohorts of IIH patients and controls without neurological disorders (n = 20/cohort) will be scanned by MRI to perform high resolution vessel wall imaging of the dural lymphatics, sinus and cerebral veins.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 28, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 9, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

March 10, 2023

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 11, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 11, 2025

Completed
Last Updated

October 6, 2025

Status Verified

January 1, 2025

Enrollment Period

2.1 years

First QC Date

February 28, 2023

Last Update Submit

October 1, 2025

Conditions

Keywords

Dural venous stenosesMRIVessel Wall ImagingHeadachePapilledema

Outcome Measures

Primary Outcomes (1)

  • Morphometric study of the dural lymphatic network in patients with IIH vs controls

    Measurement of the dural lymphatic network volume (mm3) in patients with IIH vs controls

    Immediate

Secondary Outcomes (3)

  • Characterization of lateral sinus stenoses using high resolution vessel wall imaging in patients with IIH

    Immediate

  • Morphometric study of the cervical lymphatic network in patients with IIH vs controls

    Immediate

  • Comparison of the volumes of the different compartments of the skull in patients with IIH vs controls

    Immediate

Study Arms (2)

Patients with IIH

EXPERIMENTAL

Female patients with IIH between 20 and 40 years old

Diagnostic Test: 3T MRI with Gadobutrol injection

Healthy volunteers

ACTIVE COMPARATOR

Female healthy volunteers between 20 and 40 years old

Diagnostic Test: 3T MRI with Gadobutrol injection

Interventions

MRI will be performed in all participants before and after Gadobutrol injection

Healthy volunteersPatients with IIH

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • For all participants:
  • Age \> 18 years and ≤ 40 years female gender Absence of previous neurosurgical or endovascular neurological history Participant able to express her consent Medical insurance
  • For participants with IIH No required criterion of severity or evolution of IIH Definite diagnosis of IIH according to Dandy's modified criteria. All of the following criteria must be met and verified by medical reports or certificates from a neurologist, especially the value of the CSF opening pressure measured during the lumbar puncture must be clearly noted on the reports
  • History of papilledema
  • Normal neurological examination, except for paralysis of the VIth cranial nerve
  • Neuroimaging: normal cerebral parenchyma without hydrocephalus, intracranial expansive process, or structural anomaly, and absence of meningeal contrast enhancement in MRI without and with contrast product. A venous angio-MRI is necessary in atypical patients; if MRI is unavailable or contraindicated, a brain scan without and with contrast product can be done in combination with a venous angioscan with contrast injection
  • Normal CSF composition
  • High CSF opening pressure (≥ 25 cm of water) obtained from a lumbar puncture performed in lateral decubitus
  • For healthy volunteers No previous history of neurological or neurosurgical disorder

You may not qualify if:

  • For participants with IIH Participants with a probable but not definite diagnosis of IIH according to the Dandy modified criteria
  • For healthy volunteers Chronic headaches (\>15 days per month) Uncorrected and/or unlabeled visual symptoms (visual blurriness, diplopia, visual eclipses, papilledema, optic atrophy)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Neuroradiologie, Groupe Hospitalier Pitié Salpêtrière, Paris, France

Paris, Île-de-France Region, 75000, France

Location

Related Publications (10)

  • Ahn JH, Cho H, Kim JH, Kim SH, Ham JS, Park I, Suh SH, Hong SP, Song JH, Hong YK, Jeong Y, Park SH, Koh GY. Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid. Nature. 2019 Aug;572(7767):62-66. doi: 10.1038/s41586-019-1419-5. Epub 2019 Jul 24.

    PMID: 31341278BACKGROUND
  • Lenck S, Radovanovic I, Nicholson P, Hodaie M, Krings T, Mendes-Pereira V. Idiopathic intracranial hypertension: The veno glymphatic connections. Neurology. 2018 Sep 11;91(11):515-522. doi: 10.1212/WNL.0000000000006166.

    PMID: 30201744BACKGROUND
  • Ma Q, Ineichen BV, Detmar M, Proulx ST. Outflow of cerebrospinal fluid is predominantly through lymphatic vessels and is reduced in aged mice. Nat Commun. 2017 Nov 10;8(1):1434. doi: 10.1038/s41467-017-01484-6.

    PMID: 29127332BACKGROUND
  • Louveau A, Herz J, Alme MN, Salvador AF, Dong MQ, Viar KE, Herod SG, Knopp J, Setliff JC, Lupi AL, Da Mesquita S, Frost EL, Gaultier A, Harris TH, Cao R, Hu S, Lukens JR, Smirnov I, Overall CC, Oliver G, Kipnis J. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat Neurosci. 2018 Oct;21(10):1380-1391. doi: 10.1038/s41593-018-0227-9. Epub 2018 Sep 17.

    PMID: 30224810BACKGROUND
  • Lenck S, Nicholson P. Cerebral Venous Wall Diseases: The Other Side of the Picture. AJNR Am J Neuroradiol. 2021 Jan;42(2):297-298. doi: 10.3174/ajnr.A6914. Epub 2021 Jan 7. No abstract available.

    PMID: 33414232BACKGROUND
  • Lenck S, Vallee F, Labeyrie MA, Touitou V, Saint-Maurice JP, Guillonnet A, Tantot A, Crassard I, Bernat AL, Houdart E. Stenting of the Lateral Sinus in Idiopathic Intracranial Hypertension According to the Type of Stenosis. Neurosurgery. 2017 Mar 1;80(3):393-400. doi: 10.1227/NEU.0000000000001261.

    PMID: 27218234BACKGROUND
  • Kedra A, Lahlouh M, Shotar E, Chenoune Y, Boistard L, Boussac A, Shor N, Savatovsky J, Hage R, Touitou V, Nicholson P, Clarencon F, Piotin M, Blanc R, Lenck S. Global collapse of the dural sinuses after venous stenting in idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry. 2021 Dec;92(12):1363-1364. doi: 10.1136/jnnp-2020-325717. Epub 2021 Jun 24. No abstract available.

    PMID: 34168084BACKGROUND
  • Absinta M, Ha SK, Nair G, Sati P, Luciano NJ, Palisoc M, Louveau A, Zaghloul KA, Pittaluga S, Kipnis J, Reich DS. Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI. Elife. 2017 Oct 3;6:e29738. doi: 10.7554/eLife.29738.

    PMID: 28971799BACKGROUND
  • Xie Y, Yang Q, Xie G, Pang J, Fan Z, Li D. Improved black-blood imaging using DANTE-SPACE for simultaneous carotid and intracranial vessel wall evaluation. Magn Reson Med. 2016 Jun;75(6):2286-94. doi: 10.1002/mrm.25785. Epub 2015 Jul 8.

    PMID: 26152900BACKGROUND
  • Jacob L, de Brito Neto J, Lenck S, Corcy C, Benbelkacem F, Geraldo LH, Xu Y, Thomas JM, El Kamouh MR, Spajer M, Potier MC, Haik S, Kalamarides M, Stankoff B, Lehericy S, Eichmann A, Thomas JL. Conserved meningeal lymphatic drainage circuits in mice and humans. J Exp Med. 2022 Aug 1;219(8):e20220035. doi: 10.1084/jem.20220035. Epub 2022 Jul 1.

    PMID: 35776089BACKGROUND

MeSH Terms

Conditions

Pseudotumor CerebriHeadachePapilledema

Condition Hierarchy (Ancestors)

Intracranial HypertensionBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsOptic Nerve DiseasesCranial Nerve DiseasesEye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
MRI will be pseudo-anonymised and blindly analyzed
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: 20 patients with IIH and 20 volunteers paired on age (20-40 yo) and gender will be prospectively enrolled in the study
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 28, 2023

First Posted

March 9, 2023

Study Start

March 10, 2023

Primary Completion

April 11, 2025

Study Completion

May 11, 2025

Last Updated

October 6, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations